NCT04602871View on ClinicalTrials.gov

Early Detection of COVID-19 Using Breath Analysis - Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

July 3, 2020

Primary Completion Date

January 30, 2021

Study Completion Date

January 30, 2021

Conditions
Covid19
Interventions
DIAGNOSTIC_TEST

Breath Biopsy

Breath Biopsy sampling using the ReCIVA® Breath Sampler

Trial Locations (2)

Unknown

Soroka Medical Center, Beersheba

Meir Medical Center, Kfar Saba

All Listed Sponsors
lead

Scentech Medical Technologies Ltd

INDUSTRY

NCT04602871 - Early Detection of COVID-19 Using Breath Analysis - Feasibility Study | Biotech Hunter | Biotech Hunter